Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study
Background There is limited evidence to support use of fixed dose combination (FDC) drugs in the treatment of psychiatric disorders. This study aimed to examine the sales and regulatory status of psychotropic FDCs in India, in the context of two government regulatory initiatives.Methods Official doc...
Saved in:
Main Authors: | Paul Bogowicz (Author), Aashna Mehta (Author), Shruti Choudhary (Author), Petra Brhlikova (Author), Peter Roderick (Author), Patricia McGettigan (Author), Habib Hasan Farooqui (Author), Aditya Narain Sharma (Author), Allyson M. Pollock (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship
by: Patricia McGettigan, et al.
Published: (2017) -
Evaluating the impact of price regulation (Drug Price Control Order 2013) on antibiotic sales in India: a quasi-experimental analysis, 2008-2018
by: Sakthivel Selvaraj, et al.
Published: (2022) -
Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015)
by: Richard Ofori-Asenso, et al.
Published: (2016) -
Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
by: Ayo-Oley Baldeh, et al.
Published: (2023) -
Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil
by: Fernando de Sá Del Fiol, et al.
Published: (2023)